Arrowstreet Capital
AGN

Arrowstreet Capital’s Allergan Inc AGN Stock Holding History

Arrowstreet Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,366
Closed -$600K – 1446
2014
Q3 		$600K Buy
+3,366
New +$559K ﹤0.01% 805
2014
Q2 		– Sell
-81,756
Closed -$10.1M – 1388
2014
Q1 		$10.1M Buy
+81,756
New +$9.95M 0.06% 278
2013
Q4 		– Sell
-10,358
Closed -$937K – 1444
2013
Q3 		$937K Sell
10,358
-125,030
-92% -$11.2M 0.01% 689
2013
Q2 		$11.4M Buy
+135,388
New +$14M 0.09% 204

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Arrowstreet Capital's AGN Position: Q4 2014 in Review

Arrowstreet Capital sold out of Allergan Inc (AGN) in Q4 2014, closing a stake of 3,366 shares — an estimated $600K sold.

Arrowstreet Capital first reported a position in AGN in Q2 2013 and held it in 4 quarters. The position peaked at $11.4M in Q2 2013. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Arrowstreet Capital reported no remaining Allergan Inc position as of Q4 2014 after selling out during the quarter.
  • Arrowstreet Capital sold 3,366 Allergan Inc shares in Q4 2014, an estimated $600K.
  • Arrowstreet Capital first reported a position in Allergan Inc in Q2 2013 and held it in 4 quarters.
  • Arrowstreet Capital's Allergan Inc position peaked at $11.4M in Q2 2013.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Arrowstreet Capital's 13F filing for Q4 2014, filed 13 Feb 2015.